Print this page
-
A Phase II Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer.
Protocol: 072407Principal Investigator:
- Salma Jabbour
Applicable Disease Sites: Anus -
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients with Refractory Advanced/Metastatic Microsatellite Stable Colorectal Cancer.
Protocol: 072503Principal Investigator:
- Howard Hochster
Applicable Disease Sites: Colon -
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment.
Protocol: 072504Principal Investigator:
- Howard Hochster
Applicable Disease Sites: Colon
Esophagus
Larynx
Lip, Oral Cavity and Pharynx
Other Digestive Organ
Pancreas
Rectum
Small Intestine
Stomach -
A Phase 3, Multicenter, Randomized, Open-Label, Study Evaluating the Efficacy and Safety of Nanvuranlat in Patients with Previously Treated Advanced Biliary Tract Cancer.
Protocol: 072509Principal Investigator:
- Stacey Stein
Applicable Disease Sites: Other Digestive Organ -
A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer.
Protocol: 072511Principal Investigator:
- Patrick Boland
Applicable Disease Sites: Colon -
A Randomized Phase II/III Trial of Intraperitoneal Paclitaxel Plus Systemic Treatment vs Systemic Treatment Alone in Gastric Carcinomatosis STOPGAP II
Protocol: 072603Principal Investigator:
- Haejin In
Applicable Disease Sites: Esophagus
Stomach -
Personalized Oncology Promoting Equity for Black Lives (PROPEL).
Protocol: 132309Principal Investigator:
- Anita Y Kinney
Applicable Disease Sites: Breast
Colon
Corpus Uteri
Ovary
Pancreas
Prostate -
PIONEER (Preparing for Implementation and Optimization of aNal scrEEning and tReatment)
Protocol: 132311Principal Investigator:
- Racquel Kohler
Applicable Disease Sites: Anus -
Tracking Health and Resilience in Metastatic Colorectal Cancer: THRIVE-MCRC
Protocol: 132314Principal Investigator:
- Lisa Paddock
Applicable Disease Sites: Colon -
Biopsychosocial Study to Track Health and Responses to Living with Cancer in New Jersey (BioTHRIVE-NJ)
Protocol: 132416Principal Investigator:
- Lisa Paddock
Applicable Disease Sites: Colon
Rectum -
Translating Innovations in Cancer Screening into Substance Use Disorder
Care Settings (Just in Time)
Protocol: 132602Principal Investigator:
- Ana Tergas
Applicable Disease Sites: Cervix
Colon -
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer.
Protocol: 152301Principal Investigator:
- Salma Jabbour
Applicable Disease Sites: Rectum -
Personalized Oncology Promoting Equity for Black Lives (PROPEL).
Protocol: 132309Principal Investigator:
- Anita Y Kinney
Applicable Disease Sites: Breast
Colon
Corpus Uteri
Ovary
Pancreas
Prostate -
PIONEER (Preparing for Implementation and Optimization of aNal scrEEning and tReatment)
Protocol: 132311Principal Investigator:
- Racquel Kohler
Applicable Disease Sites: Anus -
Tracking Health and Resilience in Metastatic Colorectal Cancer: THRIVE-MCRC
Protocol: 132314Principal Investigator:
- Lisa Paddock
Applicable Disease Sites: Colon -
Biopsychosocial Study to Track Health and Responses to Living with Cancer in New Jersey (BioTHRIVE-NJ)
Protocol: 132416Principal Investigator:
- Lisa Paddock
Applicable Disease Sites: Colon
Rectum